![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Eberhard Grube Lutz Buellesfeld
Publisher: Adis International
ISSN: 1175-3277
Source: American Journal of Cardiovascular Drugs, Vol.4, Iss.6, 2004-01, pp. : 355-360
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Paclitaxel-eluting stents reduce restenosis
Inpharma, Vol. 1, Iss. 1383-1384, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Paclitaxel-eluting stents reduce restenosis
Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Paclitaxel-eluting stents effective in various subgroups
Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Sirolimus- top paclitaxel-eluting stents in small-vessel disease
Inpharma, Vol. 1, Iss. 1606, 2007-01 ,pp. :